Advertisement

Making Sense of Early High-dose Intravenous Vitamin C in Ischemia/Reperfusion Injury

  • A. M. E. Spoelstra-de ManEmail author
  • P. W. G. Elbers
  • H. M. Oudemans‐van Straaten
Part of the Annual Update in Intensive Care and Emergency Medicine book series (AUICEM)

Introduction

In Europe, each day over 1,000 patients have a cardiac arrest [1]. Only half of these patients arrive at the hospital alive. Of these survivors, 50% will still die or remain severely disabled due to the post‐cardiac arrest syndrome [2]. Apart from targeted temperature management, there is no effective therapy to improve prognosis. Crucial to the post‐cardiac arrest syndrome is the overwhelming oxidative stress caused by systemic ischemia/reperfusion injury and leading to endothelial dysfunction with cardiovascular failure, brain damage and death. These effects provide a strong rationale for targeting this overwhelming oxidative stress with antioxidant therapy.

Recently, early high‐dose intravenous (i. v.) vitamin C for the treatment of sepsis has attracted a lot of attention in the critical care community as well as in the lay press. The potential benefit of vitamin C, the main circulating antioxidant, has indeed recently been shown in this population. High‐dose...

References

  1. 1.
    Grasner JT, Bottiger BW, Bossaert L (2014) EuReCa ONE – ONE month – ONE Europe – ONE goal. Resuscitation 85:1307–1308CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Beesems JA, Stieglis R, Koster RW (2012) Reanimatie buiten het ziekenhuis in Noord-Holland en twente: resultaten ARREST-onderzoek. In: Koopman C, van Dis I, Visseren FLJ, Vaartjes I, Bots ML (eds) Hart- en vaatziekten in Nederland 2012, cijfers over risicofactoren, ziekte en sterfte. Hartstichting, Den Haag, pp 2006–2011Google Scholar
  3. 3.
    Fowler AA III, Syed AA, Knowlson S et al (2014) Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 12:32CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Zabet MH, Mohammadi M, Ramezani M, Khalili H (2016) Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract 5:94–100CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J (2016) Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151:1229–1238CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Huet O, Dupic L, Batteux F et al (2011) Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med 39:1712–1720CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Rice ME, Lee EJ, Choy Y (1995) High levels of ascorbic acid, not glutathione, in the CNS of anoxia-tolerant reptiles contrasted with levels in anoxia-intolerant species. J Neurochem 64:1790–1799CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Grooth HJ, Spoelstra-de Man AME, Oudemans-van Straaten HM (2014) Early plasma Vitamin C concentration, organ dysfunction and ICU mortality. Intensive Care Med 40(Suppl 1):S199 (abst)Google Scholar
  9. 9.
    Borrelli E, Roux-Lombard P, Grau GE et al (1996) Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 24:392–397CrossRefPubMedCentralGoogle Scholar
  10. 10.
    van Zanten AR, Sztark F, Kaisers UX et al (2014) High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA 312:514–524CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC (2014) Vitamin C revisited. Crit Care 18:460CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Levine M, Padayatty SJ, Espey MG (2011) Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2:78–88CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Long CL, Maull KI, Krishnan RS et al (2003) Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 109:144–148CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Tanaka H, Matsuda T, Miyagantani Y et al (2000) Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg 135:326–331CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Hoffer LJ, Levine M, Assouline S et al (2008) Phase I clinical trial of i. v. ascorbic acid in advanced malignancy. Ann Oncol 19:1969–1974CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Tsai MS, Huang CH, Tsai CY et al (2011) Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock. Intensive Care Med 37:2033–2040CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Tsai MS, Huang CH, Tsai CY et al (2014) Combination of intravenous ascorbic acid administration and hypothermia after resuscitation improves myocardial function and survival in a ventricular fibrillation cardiac arrest model in the rat. Acad Emerg Med 21:257–265CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Motl J, Radhakrishnan J, Ayoub IM, Grmec S, Gazmuri RJ (2014) Vitamin C compromises cardiac resuscitability in a rat model of ventricular fibrillation. Am J Ther 21:352–357CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Okazaki T, Otani H, Shimazu T et al (2011) Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart. Free Radic Res 45:1173–1183CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Klein HH, Pich S, Lindert S et al (1989) Combined treatment with vitamins E and C in experimental myocardial infarction in pigs. Am Heart J 118:667–673CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Doppelfeld IS, Parnham MJ (1992) Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts. Methods Find Exp Clin Pharmacol 14:419–430PubMedPubMedCentralGoogle Scholar
  22. 22.
    Mickle DA, Li RK, Weisel RD et al (1989) Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. Ann Thorac Surg 47:553–557CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Chatziathanasiou GN, Nikas DN, Katsouras CS et al (2012) Combined intravenous treatment with ascorbic acid and desferrioxamine to reduce myocardial reperfusion injury in an experimental model resembling the clinical setting of primary PCI. Hellenic J Cardiol 53:195–204PubMedPubMedCentralGoogle Scholar
  24. 24.
    Skyschally A, Schulz R, Gres P, Korth HG, Heusch G (2003) Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol 284:H698–H703CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Nikas DN, Chatziathanasiou G, Kotsia A et al (2008) Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model. Curr Ther Res Clin Exp 69:423–439CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Guaiquil VH, Golde DW, Beckles DL, Mascareno EJ, Siddiqui MA (2004) Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med 37:1419–1429CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Gao F, Yao CL, Gao E et al (2002) Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther 301:543–550CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Tan DX, Manchester LC, Reiter RJ et al (1998) Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 25:184–191CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Karahaliou A, Katsouras C, Koulouras V et al (2008) Ventricular arrhythmias and antioxidative medication: experimental study. Hellenic J Cardiol 49:320–328PubMedPubMedCentralGoogle Scholar
  30. 30.
    Woodward B, Zakaria MN (1985) Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 17:485–493CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Nishinaka Y, Sugiyama S, Yokota M, Saito H, Ozawa T (1992) The effects of a high dose of ascorbate on ischemia-reperfusion-induced mitochondrial dysfunction in canine hearts. Heart Vessel 7:18–23CrossRefGoogle Scholar
  32. 32.
    Molyneux CA, Glyn MC, Ward BJ (2002) Oxidative stress and cardiac microvascular structure in ischemia and reperfusion: the protective effect of antioxidant vitamins. Microvasc Res 64:265–277CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Delafontaine P, Anwar A (2010) Vitamin C and percutaneous coronary intervention. Jacc Cardiovasc Interv 3:230–232CrossRefPubMedCentralGoogle Scholar
  34. 34.
    Basili S, Tanzilli G, Mangieri E et al (2010) Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. Jacc Cardiovasc Interv 3:221–229CrossRefGoogle Scholar
  35. 35.
    Wang ZJ, Hu WK, Liu YY et al (2014) The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention. Can J Cardiol 30:96–101CrossRefGoogle Scholar
  36. 36.
    Guan W, Osanai T, Kamada T et al (1999) Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn Circ J 63:924–928CrossRefGoogle Scholar
  37. 37.
    Lassnigg A, Punz A, Barker R et al (2003) Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth 90:148–154CrossRefGoogle Scholar
  38. 38.
    Dingchao H, Zhiduan Q, Liye H, Xiaodong F (1994) The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg 42:276–278CrossRefGoogle Scholar
  39. 39.
    Sisto T, Paajanen H, Metsa-Ketela T et al (1995) Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg 59:1519–1523CrossRefGoogle Scholar
  40. 40.
    Hu X, Yuan L, Wang H et al (2017) Efficacy and safety of vitamin C for atrial fibrillation after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. Int J Surg 37:58–64CrossRefPubMedCentralGoogle Scholar
  41. 41.
    Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J (1978) Free radicals in cerebral ischemia. Stroke 9:445–447CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Huang J, Agus DB, Winfree CJ et al (2001) Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci Usa 98:11720–11724CrossRefPubMedCentralGoogle Scholar
  43. 43.
    Mack WJ, Mocco J, Ducruet AF et al (2006) A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery 59:383–388CrossRefPubMedCentralGoogle Scholar
  44. 44.
    Song J, Park J, Kim JH et al (2015) Dehydroascorbic acid attenuates ischemic brain edema and neurotoxicity in cerebral ischemia: an in vivo study. Exp Neurobiol 24:41–54CrossRefPubMedCentralGoogle Scholar
  45. 45.
    Bemeur C, Ste-Marie L, Desjardins P et al (2004) Expression of superoxide dismutase in hyperglycemic focal cerebral ischemia in the rat. Neurochem Int 45:1167–1174CrossRefPubMedCentralGoogle Scholar
  46. 46.
    Henry PT, Chandy MJ (1998) Effect of ascorbic acid on infarct size in experimental focal cerebral ischaemia and reperfusion in a primate model. Acta Neurochir (Wien) 140:977–980CrossRefGoogle Scholar
  47. 47.
    Ranjan A, Theodore D, Haran RP, Chandy MJ (1993) Ascorbic acid and focal cerebral ischaemia in a primate model. Acta Neurochir (Wien) 123:87–91CrossRefGoogle Scholar
  48. 48.
    Stamford JA, Isaac D, Hicks CA et al (1999) Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data. Brain Res 835:229–240CrossRefPubMedCentralGoogle Scholar
  49. 49.
    Kim EJ, Park YG, Baik EJ et al (2005) Dehydroascorbic acid prevents oxidative cell death through a glutathione pathway in primary astrocytes. J Neurosci Res 79:670–679CrossRefPubMedCentralGoogle Scholar
  50. 50.
    Lagowska-Lenard M, Stelmasiak Z, Bartosik-Psujek H (2010) Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke. Pharmacol Rep 62:751–756CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • A. M. E. Spoelstra-de Man
    • 1
    Email author
  • P. W. G. Elbers
    • 1
  • H. M. Oudemans‐van Straaten
    • 1
  1. 1.Department of Intensive Care Medicine, Amsterdam Cardiovascular Sciences, Amsterdam Infection and Immunity InstituteVU University Medical Center AmsterdamAmsterdamNetherlands

Personalised recommendations